ARCHIVES

Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen.

This article is from The Cancer Letter archive.

Vol. 27 No. 25 | June 22, 2001

Download PDF Visit The Full Archive

Related Articles

Oncology Groups Oppose Proposed Cuts In Medicare Payments For Cancer Drugs

October 11, 2002

JRB Wins $3.6 Million Support contract

November 29, 1974

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

Fluoride Study Update Finds No Increased Risk

October 19, 1990

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999

Blood Vessel Growth Inhibitor May Be Tested Against KS

August 16, 1991